FrieslandCampina DOMO’s new Human Milk Oligosaccharide (HMO) ingredient, 2’-fucosyllactose (2’-FL) has been officially certified to be used in infant formula in both European and US markets.
The ingredient has received EU novel food approval and achieved GRAS (Generally Recognised as Safe) status from the Food and Drug Administration (FDA) in the US. These authorisations are an important step forward in the plan of FrieslandCampina to launch its first human milk oligosaccharide by the end of the year.
Aafke Keizer, managing director of FrieslandCampina DOMO, said: “Our 75 years of expertise in infant nutrition were essential in setting up a safe, smooth production process that ensures a continuously high-quality product such as 2’-FL. DOMO is the market leader in oligosaccharides and has an extensive portfolio of infant nutrition ingredients, to which 2’-FL is the perfect addition, helping our customers to develop the next generation of infant formula.”